Lung Cancer Research Foundation (LCRF)

LCRF-Daiichi Sankyo- AstraZeneca Research Grant on Antibody Drug Conjugates

Aim: research for further understanding of the mechanism of action and biomarkers for TROP2 directed ADCs in lung cancer and HER2 directed ADCs in HER2 mutant NSCLC and primary and acquired resistance to TROP2 directed and HER2 directed ADCs. 

Funding: up to $270K for 2 years (No overhead, Non-profit) 

LCRF Minority Career Development Award (CDA) in Lung Cancer

This program aims to close the gap between the mortality rates and representation in lung cancer research by funding minority researchers with $150,000 over a period of two years.

(No overhead, Non-profit) 

www.lungcancerresearchfoundation.org/research/funding-opportunities-2023